Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sirtuin 1 Inhibiting Thiocyanates (S1th)-A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases

  • Wössner, Nathalie|||0000-0002-4402-2442
  • Alhalabi, Zayan
  • González Miranda, Jessica|||0000-0001-7732-1564
  • Swyter, Sören
  • Gan, Jin
  • Schmidtkunz, Karin
  • Zhang, Lin|||0000-0003-1998-0611
  • Vaquero, Alejandro|||0000-0002-8735-4156
  • Ovaa, Huib
  • Einsle, Oliver|||0000-0001-8722-2893
  • Sippl, Wolfgang
  • Jung, Manfred
Sirtuin 1 (Sirt1) is a NAD dependent lysine deacetylase associated with the pathogenesis of various diseases including cancer. In many cancer types Sirt1 expression is increased and higher levels have been associated with metastasis and poor prognosis. However, it was also shown, that Sirt1 can have tumor suppressing properties and in some instances even a dual role for the same cancer type has been reported. Increased Sirt1 activity has been linked to extension of the life span of cells, respectively, organisms by promoting DNA repair processes and downregulation of tumor suppressor proteins. This may have the downside of enhancing tumor growth and metastasis. In mice embryonic fibroblasts depletion of Sirt1 was shown to decrease levels of the DNA damage sensor histone H2AX. Impairment of DNA repair mechanisms by Sirt1 can promote tumorigenesis but also lower chemoresistance toward DNA targeting therapies. Despite many biological studies, there is currently just one small molecule Sirt1 inhibitor in clinical trials. Selisistat (EX-527) reached phase III clinical trials for treatment of Huntington's Disease. New small molecule Sirt1 modulators are crucial for further investigation of the contradicting roles of Sirt1 in cancer. We tested a small library of commercially available compounds that were proposed by virtual screening and docking studies against Sirt1, 2 and 3. A thienopyrimidone featuring a phenyl thiocyanate moiety was found to selectively inhibit Sirt1 with an IC of 13 μM. Structural analogs lacking the thiocyanate function did not show inhibition of Sirt1 revealing this group as key for the selectivity and affinity toward Sirt1. Further analogs with higher solubility were identified through iterative docking studies and in vitro testing. The most active compounds (down to 5 μM IC) were further studied in cells. The ratio of phosphorylated γH2AX to unmodified H2AX is lower when Sirt1 is depleted or inhibited. Our new Sirtuin 1 inhibiting thiocyanates (S1th) lead to similarly lowered γH2AX/H2AX ratios in mouse embryonic fibroblasts as Sirt1 knockout and treatment with the reference inhibitor EX-527. In addition to that we were able to show antiproliferative activity, inhibition of migration and colony forming as well as hyperacetylation of Sirt1 targets p53 and H3 by the S1th in cervical cancer cells (HeLa). These results reveal thiocyanates as a promising new class of selective Sirt1 inhibitors.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

SirT7 auto-ADP-ribosylation regulates glucose starvation response through mH2A1

  • Simonet, Nicolas G.|||0000-0001-9921-7645
  • Thackray, Joshua K.|||0000-0003-2828-452X
  • Vazquez Prat, Berta Nieves|||0000-0002-8164-3926
  • Ianni, Alessandro|||0000-0001-7398-589X
  • Espinosa-Alcantud, María Dolores|||0000-0002-1126-2458
  • Morales-Sanfrutos, J.
  • Hurtado-Bagès, Sarah|||0000-0002-6588-0876
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Buschbeck, Marcus|||0000-0002-3218-4567
  • Tischfield, J.
  • De La Torre Gómez, Gisela Carolina|||0000-0001-9363-291X
  • Esteller, M.|||0000-0003-4490-6093
  • Braun, Thomas|||0000-0002-6165-4804
  • Olivella, Mireia|||0000-0002-6035-3399
  • Serrano, L.
  • Vaquero, Alejandro|||0000-0002-8735-4156
Sirtuins are key players of metabolic stress response. Originally described as deacetylases, some sirtuins also exhibit poorly understood mono-adenosine 5'-diphosphate (ADP)-ribosyltransferase (mADPRT) activity. We report that the deacetylase SirT7 is a dual sirtuin, as it also features auto-mADPRT activity. SirT7 mADPRT occurs at a previously undefined active site, and its abrogation alters SirT7 chromatin distribution. We identify an epigenetic pathway by which ADP-ribosyl-SirT7 is recognized by the ADP-ribose reader mH2A1.1 under glucose starvation, inducing SirT7 relocalization to intergenic regions. SirT7 promotes mH2A1 enrichment in a subset of nearby genes, many of them involved in second messenger signaling, resulting in their specific up- or down-regulation. The expression profile of these genes under calorie restriction is consistently abrogated in SirT7-deficient mice, resulting in impaired activation of autophagy. Our work provides a novel perspective on sirtuin duality and suggests a role for SirT7/mH2A1.1 axis in glucose homeostasis and aging.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A complex interplay between H2A.Z and HP1 isoforms regulates pericentric heterochromatin

  • González Miranda, Jessica|||0000-0001-7732-1564
  • Bosch-Presegué, Laia|||0000-0001-8025-2416
  • Marazuela Duque, Anna|||0000-0001-6787-8668
  • Guitart-Solanes, Anna
  • Espinosa-Alcantud, María Dolores|||0000-0002-1126-2458
  • Fernandez, Agustín F.
  • Brown, Jeremy P.
  • Ausió, Juan
  • Vazquez Prat, Berta Nieves|||0000-0002-8164-3926
  • Singh, Prim B.
  • Fraga, Mario|||0000-0001-8450-2603
  • Vaquero, Alejandro|||0000-0002-8735-4156
Pericentric heterochromatin (PCH) plays an essential role in the maintenance of genome integrity and alterations in PCH have been linked to cancer and aging. HP1 α, β, and γ, are hallmarks of constitutive heterochromatin that are thought to promote PCH structure through binding to heterochromatin-specific histone modifications and interaction with a wide range of factors. Among the less understood components of PCH is the histone H2A variant H2A.Z, whose role in the organization and maintenance of PCH is poorly defined. Here we show that there is a complex interplay between H2A.Z and HP1 isoforms in PCH. While the loss of HP1α results in the accumulation of H2A.Z.1 in PCH, which is associated with a significant decrease in its mobile fraction, H2A.Z.1 binds preferentially to HP1β in these regions. Of note, H2A.Z.1 downregulation results in increased heterochromatinization and instability of PCH, reflected by accumulation of the major epigenetic hallmarks of heterochromatin in these regions and increased frequency of chromosome aberrations related to centromeric/pericentromeric defects. Our studies support a role for H2A.Z in genome stability and unveil a key role of H2A.Z in the regulation of heterochromatin-specific epigenetic modifications through a complex interplay with the HP1 isoforms.